Sath Shukla

Insider Reports History

Location
Boston, MA
Signature
/s/ Maegan Deare, Attorney-in-Fact for Sath Shukla
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sath Shukla:

Company Role Class Num Shares Value Price $ Report Date Ownership
Spero Therapeutics, Inc. CEO & President Common Stock 1,736,883 $1,354,769 $0.7800 05 Feb 2025 Direct

Insider Reports Filed by Sath Shukla

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SPRO Spero Therapeutics, Inc. 03 Feb 2025 4 -$121,160 4 CEO & President 05 Feb 2025, 20:31
SPRO Spero Therapeutics, Inc. 27 Aug 2024 1 -$3,722 4 CEO & President 29 Aug 2024, 18:36
SPRO Spero Therapeutics, Inc. 02 Aug 2024 2 -$42,646 4 CEO and President 06 Aug 2024, 19:56
SPRO Spero Therapeutics, Inc. 01 Feb 2024 3 -$107,719 4 CEO and President, Director 05 Feb 2024, 20:40
SPRO Spero Therapeutics, Inc. 28 Aug 2023 2 -$7,748 4 CEO and President, Director 30 Aug 2023, 17:20
SPRO Spero Therapeutics, Inc. 01 Aug 2023 1 $0 4 CEO and President, Director 03 Aug 2023, 16:10
SPRO Spero Therapeutics, Inc. 01 Feb 2023 2 -$17,372 4 Chief Financial Officer 03 Feb 2023, 18:41
SPRO Spero Therapeutics, Inc. 29 Aug 2022 1 -$5,378 4 Chief Financial Officer 30 Aug 2022, 17:00
SPRO Spero Therapeutics, Inc. 01 Feb 2022 2 $0 4 Chief Financial Officer 03 Feb 2022, 15:19
SPRO Spero Therapeutics, Inc. 26 Aug 2021 1 $0 4 Chief Financial Officer 30 Aug 2021, 16:15